Literature DB >> 23211831

A role for Jag2 in promoting uveal melanoma dissemination and growth.

Laura Asnaghi1, James T Handa, Shannath L Merbs, J William Harbour, Charles G Eberhart.   

Abstract

PURPOSE: Controlling the spread of uveal melanoma is key to improving survival of patients with this common intraocular malignancy. The Notch ligand Jag2 has been shown to be upregulated in primary tumors that metastasize, and we therefore investigated its role in promoting invasion and clonogenic growth of uveal melanoma cells.
METHODS: mRNA and protein expression of Notch pathway components were measured using qPCR and Western blot in uveal melanoma cell lines. Expression of Jag2 ligand was upregulated using Jag2-GFP-MSCV constructs or downregulated by sh-Jag2 in the uveal melanoma cell lines Mel285, Mel290, 92.1, and OMM1, and the effects on growth and invasion were assessed.
RESULTS: Jag2 was introduced into Mel285 and Mel290 cells, which have low baseline levels of both this ligand and Notch activity. Overall growth of the Jag2-expressing cultures increased somewhat, and a significant 3-fold increase in clonogenic growth in soft agar was also noted. Introduction of Jag2 increased motility in both wound-healing and transwell invasion assays. We also observed a significant increase in Jag2 and Hes1 mRNA in invasive OMM1 cells that had passed through a Matrigel-coated filter in the transwell assay when compared with noninvading cells. Loss-of-function studies performed in 92.1 and OMM1 lines using Jag2 shRNAs showed that downregulation of the ligand significantly suppressed cellular growth, invasion, and migration.
CONCLUSIONS: Our data suggest that Jag2 may play an important role in promoting Notch activity, growth, and metastasis in uveal melanoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23211831      PMCID: PMC4604713          DOI: 10.1167/iovs.12-10209

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  44 in total

1.  Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling.

Authors:  Huw D Lewis; Matthew Leveridge; Peter R Strack; Christine D Haldon; Jennifer O'neil; Hellen Kim; Andrew Madin; Joanne C Hannam; A Thomas Look; Nancy Kohl; Giulio Draetta; Timothy Harrison; Julie A Kerby; Mark S Shearman; Dirk Beher
Journal:  Chem Biol       Date:  2007-02

2.  Molecular separation of two signaling pathways for the receptor, Notch.

Authors:  Maude Le Gall; Cordell De Mattei; Edward Giniger
Journal:  Dev Biol       Date:  2007-12-11       Impact factor: 3.582

3.  Establishment and characterization of primary and metastatic uveal melanoma cell lines.

Authors:  G P Luyten; N C Naus; C M Mooy; A Hagemeijer; J Kan-Mitchell; E Van Drunen; V Vuzevski; P T De Jong; T M Luider
Journal:  Int J Cancer       Date:  1996-05-03       Impact factor: 7.396

4.  Prognostic implications of monosomy 3 in uveal melanoma.

Authors:  G Prescher; N Bornfeld; H Hirche; B Horsthemke; K H Jöckel; R Becher
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

Review 5.  Metastatic uveal melanoma.

Authors:  Arun D Singh; Ernest C Borden
Journal:  Ophthalmol Clin North Am       Date:  2005-03

6.  Melanomas that develop within the eye inhibit lymphocyte proliferation.

Authors:  D J Verbik; T G Murray; J M Tran; B R Ksander
Journal:  Int J Cancer       Date:  1997-11-14       Impact factor: 7.396

7.  A third-generation lentivirus vector with a conditional packaging system.

Authors:  T Dull; R Zufferey; M Kelly; R J Mandel; M Nguyen; D Trono; L Naldini
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

8.  Establishment and characterization of an uveal-melanoma cell line.

Authors:  I De Waard-Siebinga; D J Blom; M Griffioen; P I Schrier; E Hoogendoorn; G Beverstock; E H Danen; M J Jager
Journal:  Int J Cancer       Date:  1995-07-17       Impact factor: 7.396

9.  Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis.

Authors:  D Ma; J Y Niederkorn
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

10.  Vertebrate retinal ganglion cells are selected from competent progenitors by the action of Notch.

Authors:  C P Austin; D E Feldman; J A Ida; C L Cepko
Journal:  Development       Date:  1995-11       Impact factor: 6.868

View more
  13 in total

Review 1.  Drosophila as a Potential Model for Ocular Tumors.

Authors:  Daimark Bennett; Ekaterina Lyulcheva; Neville Cobbe
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

2.  MicroRNA-876-3p functions as a tumor suppressor gene and correlates with cell metastasis in pancreatic adenocarcinoma via targeting JAG2.

Authors:  Fu Yang; Wan Jun Zhao; Cong Li Jia; Xiao Kai Li; Qiang Wang; Zi Li Chen; De Quan Jiang
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

3.  Cordycepin (3'-Deoxyadenosine) Suppresses Heat Shock Protein 90 Function and Targets Tumor Growth in an Adenosine Deaminase-Dependent Manner.

Authors:  Su-Chan Lee; Lujain Alaali; HyukJean Kwon; Mohammed Rigi; Charles G Eberhart
Journal:  Cancers (Basel)       Date:  2022-06-25       Impact factor: 6.575

4.  High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.

Authors:  Wei Li; Min Liu; Yuan Feng; Yan-Fei Huang; Yun-Fei Xu; Jian-Ping Che; Guang-Chun Wang; Jun-Hua Zheng
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

5.  ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma.

Authors:  Laura Asnaghi; David T White; Nolan Key; Joshua Choi; Alka Mahale; Hind Alkatan; Deepak P Edward; Sahar M Elkhamary; Saleh Al-Mesfer; Azza Maktabi; Christopher G Hurtado; Grace Y Lee; Angel M Carcaboso; Jeff S Mumm; Leen Abu Safieh; Charles G Eberhart
Journal:  Oncogene       Date:  2018-11-06       Impact factor: 9.867

6.  Downregulation of Nodal inhibits metastatic progression in retinoblastoma.

Authors:  Laura Asnaghi; David T White; Lynn Yoon; Antoinette Price; Grace Y Lee; Arpan Sahoo; Jeff S Mumm; Charles G Eberhart
Journal:  Acta Neuropathol Commun       Date:  2019-08-26       Impact factor: 7.801

7.  Locating potentially lethal genes using the abnormal distributions of genotypes.

Authors:  Xiaojun Ding; Xiaoshu Zhu
Journal:  Sci Rep       Date:  2019-07-22       Impact factor: 4.379

8.  EMT-associated factors promote invasive properties of uveal melanoma cells.

Authors:  Laura Asnaghi; Gülçin Gezgin; Arushi Tripathy; James T Handa; Shannath L Merbs; Pieter A van der Velden; Martine J Jager; J William Harbour; Charles G Eberhart
Journal:  Mol Vis       Date:  2015-08-25       Impact factor: 2.367

9.  Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation.

Authors:  Laura Asnaghi; Michael H Lin; Kah Suan Lim; Kah Jing Lim; Arushi Tripathy; Murilo Wendeborn; Shannath L Merbs; James T Handa; Akrit Sodhi; Eli E Bar; Charles G Eberhart
Journal:  PLoS One       Date:  2014-08-28       Impact factor: 3.240

10.  Targeting Notch signaling as a novel therapy for retinoblastoma.

Authors:  Laura Asnaghi; Arushi Tripathy; Qian Yang; Harpreet Kaur; Allison Hanaford; Wayne Yu; Charles G Eberhart
Journal:  Oncotarget       Date:  2016-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.